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Normal human kcratinocytcs show chemotactic behavior towards interlcukin-8 (IL-g). Under physiological conditions this cytokine seems to be 
present in an equilibrium between monomeric and dimeric forms, as indicutcd by Wesum blotiing dala. Radioligand binding studies uggest that 
keralinocyte chemotaxis mediated by rcceplors pecilic for IL-8 dimcrs. IL-8 rcceplor-specific mRNA can be detected ina keratinocytc cell lint 
by polymerasc hain reaction. 
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1. 1NTRODUCTlON 
The possible involvement of intcrleukin-8 (lL-8) in 
various inflammatory skin diseases, particularly psoria- 
sis, has been subject of a number of recent studies [l-3]. 
IL-8 has been described as a potent stimulator for neu- 
trophils [4,53 and T-lymphocytes [6], but it may also 
directly influence the function of epidermal cells. Since 
chemotactic effects of IL-8 on epidermal cell lines (SCL- 
II, HaCat) had been described [7], we were interested 
whether this proinflammatory cytokine could influence 
the chemotaxis of normal human cpidermal cells as 
well. The directed migration of human keratinocytes i
dependent upon the presence of specific cell surface 
receptors. Therefore, to study the putative IL-8 recep- 
tors, radioligand binding assays with [lz51]IL-8, and 
mRNA-PCR specific for the lL-8 receptor from neutro- 
phils [IS] were performed on cultured normal human 
keratinocytes. Specificity of binding was assessed by 
competition studies with Lhe chemotactic peptides 
fMLP and NAP-2, as well as with the endothelial 79 
amino acid form of IL-8. To compare the binding char- 
acteristics of IL-8 on various cell types, human neutro- 
phils and NIH 3T3 cells were included in the study. 
Electrophorcsis of unlabeled IL-8 and IXJ-IL-8 was performd on 
SDS-PAGE as described 191. Bands were clectro-blotted to Fluoro- 
trims membranes (Pall, Porwmourh, UK). Filters were incubated with 
goat ami-human IL-8 ncutralieingantiscrum (R&DTechnology, Min- 
neapolis. USA). Bound primary antibody was visualized by first incu- 
bating with donkey anti-goal IgG antiserum (I@) coupled to
phosphodicstcrasc (Boehringcr Mannbcim, Germany: dilution I:2,5OC 
in PBS) and subsequemly with 3.3’.4,4’,+ztraaminobiphcnyl (DAB; 
Sigma, Dciscnhofcn) as enzyme substrate. 
Normal keratinocytes wcrc isolated from newborn foreskin and 
cullurcd as described earlier [IO]. Human squamous cell carcinoma 
cells (SCL-II) and 373 fibroblasts were grown in DMEM containing 
IO% FCS. 
Polymorphonuclear lcukccytcs (PMNL) were prepared from nor- 
mal human volunteers by Ficoll/Hypaque gradient ccntrifugaalion as
described [I I]. 
Cultured human kcralinocytes, SCL-II cells, NIH 3T3 cells and 
PMNL (2 x IO5 cells each) were incubated with 2 nM [1’51]IL-8 at 4OC 
for 4 h in rhe presence of increasing conccntrdtions (0. I nM-I PM) 
of unlabeled IL-8 (73aa form), endothclial !L-8 (79aa form). NAP-2 
or MLP (Sigma. Dciscnhofcn. Germany). Cells wcrc washed, lyscd 
and cell bound radioactiviiy was measured ingamma-counter (Phar- 
macia-LKB. Uppsaltl. Sweden). 
2. MATERIALS AND METHODS 
2. I. Labding crf IL-8 
Human recombinant intcrlcukin-8 containing 72 amino acids wilh 
a molecular weight of 8 kDa was iodinatcd by the chloraminc-T 
method [8] to obtain a specific activity of 350-500 Ci/mmol. 
Corrcsponrlozcr uddrcss: T. Ruzicka, Dermalologischc Klinik dcr 
LMU, Frauenlobslr. 9-l 1, 8 Mllnchen 2. Germany. Fax: (49) (~9) 
5 I GO-4664. 
2.0. Clrzrrln tosi.Y a.wq 
Chcmotaxis of freshly separated human cpidcrmal cells was analy- 
sed in modified Boyden chambsrs with membrdnes of IOym pore size 
as described [7]. 
mRNA-PCR: Total RNA from SCLII cells was separated from 
DNA using LiCI. From the cDNA sequence published for the high 
al’lini~y rcccplor in human ncutrophils 1151 primers were synthesized 
Ilankiny it 300 bp fragmcnl (L-primer: S’CAG-ATCCACAGATGT- 
GGGATY: R-primer: STCCAGCCATTCACClTGCAG3’). Re- 
vcrsc lrans~riplion was specifically primed using the R-primer. After 
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30 amplification cycles the product was visualized by EtBr-stained 
agarose gel clcctrophoresis. 
3. RESULTS AND DISCUSSION 
Freshly separated human epidermal cells showed sig- 
nificant chemotactic response towards IL-S. The magni- 
tude of the response was comparable to that of Abro- 
blast conditioned medium (FCM) (Fig. 1). These find- 
ings in normal epidermal cells correlate very well with 
earlier studies in the epidermai ceii iins XL-II [7]. Since 
it is well established that chemotaxis is mediated 
through speci5c receptors we tried to identify IL-8 re- 
ceptors on human keratinocytes by radioligand binding 
experiments. The results of our competition binding 
studies are shown in Fig. 2. In accordance to published 
data [12] binding of ‘~51-labeleci IL-8 to PMNL could be 
displaced by excess unlabeled IL-S with a Ki of 4 nM. 
In contrast, no displacement could be obtained in NIH 
3T3 mouse fibroblasts. Surprisingly, in normal human 
keratinocytes and to a somewhat lesser degree in SCL-II 
cells increasing concentrations of unlabeled IL-8 led to 
an increase in cell bound radioactivity, This seemingly 
paradoxical phenomenon was not observed when NAP- 
2, the endothelial form of IL-8 (79aa) or fMLP were 
used as competitors (Fig. 3). In search for a reaSOna’bk 
explanation for these results we assumed concentration- 
dependent dimerization of IL-X. This assumption is 
based on the demonstration of IL-8 dimers in solution 
by NMR [14]. In fact, we could show the presence of a 
1B kDa band in PAGE which showed IL-8 im- 
munoreactivity in Western blots (Fig, 4). The data 
prove the presence of IL-8 dimers under physiological 
conditions of neutral pH. The phenomenon of concen- 
tration-dependent dimerization has a precedent in the 
dimer formation by human growth hormone [13]. Thus 
the observed increase of [1251]IL-8 binding in the pres- 
ence of cold ligand can best bc explained by concentra- 
tion-dependent formation of IL-8 dimers and dimer- 
specific receptor binding on keratinocytes. 
IL-6 concrntrrtlon InML 
Fig. I. Chemotaxis of normal human cpidermal cells. Freshly isolated 
cells were analyscd in modified Boyden chambers. Membranes had a 
pore size of IO pm. 
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Fig. 2. Comparison of different cell types in competition experiments 
using [12’1]IL-8 as radioligand. In duplicate assays cultured normal 
and carcinoma-derived (SCLII) human keratinocytes, NlM 3T3 
mouse Bbroblasts and PMNL (2 x IO’ cells each; were incubated with 
2 nM [l’sI]IL-i3 for 4 h at 4°C in the presence of increasing concentra- 
tions (0.1-I PM) of unlabelled IL-8. Cells were washed, lysed in 0.5 
N NaOtI and cell bound wdioactivity was measured in a gamma- 
counter. 
Computerized analysis of a saturation binding curve 
(not shown) suggests that the binding of [“s1]Ii-8 orig- 
inates from a specific binding (K,,=l nM, B,,,,,=14,400 
receptors/cell) superimposed by a nonspecific binding. 
Further support for the presence of specific IL-8 re- 
ceptors in epidermal cells comes from the demonstra- 
tion of mRNA transcripts by mRNA-PCR. Using prirn- 
ers specific for the high affinity IL-8 receptor described 
for PMNL. [15] an amplification product can be 
achieved showing the exact size predictable from the 
published cDNA sequence (Fig. 5). 
In summary, we could show for the first time that 
normal human kcratinocytes possess IL-8 receptors, 
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Fig. 3. Comparison of different competitors for binding of [?]lL-8 
to cultured normal keratinocytes. Incubation conditions were as dc- 
scribed under Fig. 2. 
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Fig. 4. IL-8 dimers shown by clcctrophoresis through 17.5% PAAl 
SDS. M=8 kDa monomer, D= 16 kDa dlmer. (Lane a) Autoradiogra- 
phy of5yg [‘zJI]L-8; (lane b) Western blot of 5yg IL-8 and subsequent 
immunological detection with anti-IL-8 antiserum as described in Ma- 
terials and Methods. 
- 298 bp 
Fig. 5. Eiectrophoresis of the PCR-fragment amplified from high 
affinity IL-8 receptor mRNA. For sequence of primers used forcDNA 
synthesis and amplification, see Materials and Methods. (Lane 1) 300 
bp PCR-product; (lane 2) negativecontrol; (lane 3) I kb ladder (Gibco 
BRL. Eggcnstein, Germany) as six marker. 
which are likely to be involved in IL-8 induced chcmo- 
taxis of epidermal cells. These data suggest that IL-% 
could play a role in the activation of epidermal cells in 
skin conditions with increased IL-8 levels, such as psrjri- 
asis. 
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